A Novel Cerium(IV)-Based Metal-Organic Framework for CO Chemical Fixation and Photocatalytic Overall Water Splitting.

Cerium (IV)-based metal-organic frameworks (MOFs) are highly desirable due to their unique potential in fields such as redox catalysis and photocatalysis. However, due to the high reduction potential of Ce species in solution, it is still a great challenge to synthesize Ce -MOFs with novel structures, which are extremely dominated by the hexanuclear Ce-O cluster inorganic building units (IBUs). Herein, a Ce-O IBU chain containing Ce -MOF, CSUST-3 (CSUST: Changsha University of Science and Technology), was successfully prepared using the kinetic stabilization study of UiO-66(Ce)-NDC (H NDC=2,6-naphthalenedicarboxylic acid).

Oxygen Vacancy-Rich Mixed-Valence Cerium MOF: An Efficient Separator Coating to High-Performance Lithium-Sulfur Batteries.

Mixed-valence metal-organic frameworks (MOFs) have exhibited unique potential in fields such as catalysis and gas separation. However, it is still an open challenge to prepare mixed-valence MOFs with isolated Ce(IV, III) arrays due to the easy formation of Ce under the synthetic conditions for MOFs. Meanwhile, the performance of Li-S batteries is greatly limited by the fatal shuttle effect and the slow transmission rate of Li caused by the inherent characteristics of sulfur species.

Signature Gene Identification of Cancer Occurrence and Pattern Recognition.

To identify signature genes for the pathogenesis of cancer, which provides a theoretical support for prevention and early diagnosis of cancer. The pattern recognition method was used to analyze the genome-wide gene expression data, which was collected from the The Cancer Genome Atlas (TCGA) database. For the transcription of invasive breast carcinoma, lung adenocarcinoma, lung squamous cell carcinoma, colon adenocarcinoma, renal clear-cell carcinoma, thyroid carcinoma, and hepatocellular carcinoma of the seven cancers, the signature genes were selected by means of a combination of statistical methods, such as correlation, t-test, confidence interval, etc.

Long terminal repeat sequences from virulent and attenuated equine infectious anemia virus demonstrate distinct promoter activities.

In the early 1970s, the Chinese Equine Infectious Anemia Virus (EIAV) vaccine, EIAV(DLA), was developed through successive passages of a wild-type virulent virus (EIAV(L)) in donkeys in vivo and then in donkey macrophages in vitro. EIAV attenuation and cell tropism adaptation are associated with changes in both envelope and long terminal repeat (LTR). However, specific LTR changes during Chinese EIAV attenuation have not been demonstrated.